Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Dimethyl Fumarate (Official Atc Code: L04Ax07)

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Dimethyl Fumarate (Official Atc Code: L04Ax07) in Pharmaceuticals. The tender was released on Nov 26, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) By Means Of An Open-House Model For The Active Ingredient Dimethyl Fumarate (Official Atc Code: L04Ax07)

Deadline - Jan 31, 2026

MT reference number - 98402416

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 98402416

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient dimethyl fumarate (official ATC code: L04AX07). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. Please note that the purchase quantity is unknown, as this depends on demand and the d

Mt Ref Id - 98402416

Deadline - Jan 31, 2026

Share

Similar Tenders :